9:00 AM - 5:00 PM

Our Hours Mon. - Fri.

310.774.1437

Call Us For Free Consultation

Facebook

Twitter

Gibson Dunn, Latham Steer Ultragenyx’s $304M Follow-On

Tiomkin Law Offices of Elliott Tiomkin > Legal News  > Gibson Dunn, Latham Steer Ultragenyx’s $304M Follow-On

Gibson Dunn, Latham Steer Ultragenyx’s $304M Follow-On

Law360 (February 27, 2019, 5:05 PM EST) — Rare disease drug company Ultragenyx Pharmaceuticals Inc. priced a follow-on offering late Tuesday that raised $304 million to launch and develop new products, represented by Gibson Dunn & Crutcher LLP while…

Call Now ButtonCall For Free Consultation